Prion protein aggregation reverted by low temperature in transfected cells carrying a prion protein gene mutation

94Citations
Citations of this article
51Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Prion diseases are characterized by the conversion of the normal cellular prion protein (PrP(C)), a glycoprotein that is anchored to the cell membrane by a glycosylphosphatidylinositol moiety, into an isoform that is protease-resistant (PrP(res)) and pathogenic. In inherited prion diseases, mutations in the priori protein (PrP(M)) engender the conversion of PrP(M) into PrP(res). We developed a cell model of Gerstmann-Straussler-Scheinker disease, a neurodegenerative condition characterized by PrP(M)-containing amyloid deposits and neuronal loss, by expressing the Gerstmann-Straussler- Scheinker haplotype Q217R-129V in human neuroblastoma cells. By comparison to PrP(C), this genotype results in the following alterations of PrPM: 1) expression of an aberrant form lacking the glycosylphosphatidylinositol anchor, 2) increased aggregation and protease resistance, and 3) impaired transport to the cell surface. Most of these alterations are temperature- sensitive, indicating that they are due to misfolding of PrP(M).

Cite

CITATION STYLE

APA

Singh, N., Zanusso, G., Chen, S. G., Fujioka, H., Richardson, S., Gambetti, P., & Petersen, R. B. (1997). Prion protein aggregation reverted by low temperature in transfected cells carrying a prion protein gene mutation. Journal of Biological Chemistry, 272(45), 28461–28470. https://doi.org/10.1074/jbc.272.45.28461

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free